HomepageMedicineAstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis Medicine AstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis admin Posted on May 8, 2024 Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostMore ghost malls in the making as consumers shun poorly managed shopping centres Next PostHow Much Money Did This Year’s Met Gala Raise? You Might Also Like Medicine Pharma Marketing's Top Movers and Shakers in 2024 admin December 21, 2024 Medicine EXO Biologics CEO Discusses Innovation in Developing Exosome Therapies admin June 25, 2024 Medicine Pharma Pulse 5/17/24: AI & ML Through the Eyes of the FDA, Johnson & Johnson to Acquire Proteologix & more admin May 20, 2024 Medicine Astellas, AviadoBio Strike Exclusive Option, License Agreement for Potential Treatment for Frontotemporal Dementia admin October 9, 2024
Medicine Pharma Pulse 5/17/24: AI & ML Through the Eyes of the FDA, Johnson & Johnson to Acquire Proteologix & more admin May 20, 2024
Medicine Astellas, AviadoBio Strike Exclusive Option, License Agreement for Potential Treatment for Frontotemporal Dementia admin October 9, 2024